Shares of CVS Health Corporation (NYSE:CVS – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twenty-three brokerages that are presently covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $94.8182.
Several equities research analysts have commented on CVS shares. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $91.00 target price on shares of CVS Health in a research note on Tuesday, January 6th. Piper Sandler reiterated an “overweight” rating and set a $101.00 price objective (up previously from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Truist Financial set a $100.00 price objective on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Evercore ISI lifted their price target on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th.
View Our Latest Stock Report on CVS Health
CVS Health Trading Up 2.5%
CVS Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is 700.00%.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of CVS. Avion Wealth grew its holdings in CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. grew its position in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the period. Corundum Trust Company INC bought a new stake in shares of CVS Health in the third quarter valued at approximately $29,000. Finally, Ares Financial Consulting LLC bought a new stake in shares of CVS Health during the 4th quarter valued at $29,000. 80.66% of the stock is currently owned by institutional investors.
CVS Health Company Profile
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Further Reading
- Five stocks we like better than CVS Health
- The day the gold market broke
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Trump Planning to Use Public Law 63-43: Prepare Now
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
